Literal source text
Lobbying issues and bill citations
HCR · Health Issues
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Literal federal measure citations: H.R.946, H.R.10571, H.R.1518
MMM · Medicare/Medicaid
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Literal federal measure citations: H.R.1518
PHA · Pharmacy
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
Literal federal measure citations: H.R.946
MED · Medical/Disease Research/Clinical Labs
H.R.10571, Surge to Save Newborns Act.
Literal federal measure citations: H.R.10571
TAX · Taxation/Internal Revenue Code
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
Literal federal measure citations: H.R.1414
TRD · Trade (domestic/foreign)
Treatment of orphan drugs under tariff proposals.
